SCHEMBL37495

SCHEMBL37495

COP(=O)(O)c1sc2nc(Cc3ccc(Cl)c(Cl)c3)[nH]c(=O)c2c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNASEH1 O60930 1/20 0.46
KDM4E B2RXH2 4/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
PIP4K2A P48426 1/20 0.40
PDE5A O76074 1/20 0.40
MEN1 O00255 1/20 0.39
CCNE2 O96020 6/20 0.39
CCNE1 P24864 6/20 0.39
CDK2 P24941 6/20 0.39
CDK4 P11802 5/20 0.39
CCND1 P24385 5/20 0.39
CCNB2 O95067 4/20 0.39
CDK1 P06493 4/20 0.39
CCNB1 P14635 4/20 0.39
CCNB3 Q8WWL7 4/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38887 0.90 RNASEH1 (0.49) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL21504938 0.80 KMT2A (0.58) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL16175762 0.78 RNASEH1 (0.54) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL3491664 0.78 RNASEH1 (0.58) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL38179 0.78 PDE5A (0.46) RNASEH1KDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL37998 0.77 RNASEH1 (0.49) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL3492896 0.77 RNASEH1 (0.57) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL38376 0.77 RNASEH1 (0.52) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL4514505 0.77 KMT2A (0.65) RNASEH1KDM4EMAPTALDH1A1KMT2A
SCHEMBL37691 0.77 MAPT (0.50) RNASEH1KDM4EMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012004900-A1 THIENOPYRIMIDINE COMPOUNDS ASKA PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 WO disclosed